Synthetic Biologics, Inc. (NYSE: SYN) is trading up 14% in pre-open trade after the company announced that its Investigational New ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE